Regent Pacific Group Ltd

00575

Company Profile

  • Business description

    Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.

  • Contact

    5 Queen's Road Central
    8th Floor, Henley Building
    Hong Kong
    HKG

    T: +852 25146111

    https://www.endurancerp.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    16

Stocks News & Analysis

stocks

ASX iron ore player downgraded ahead of earnings

Rising costs and delayed production drive fair value cut for ASX iron ore player.
stocks

Global tensions drive profitability for ASX energy provider

Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks

ASX energy share undervalued ahead of earnings

Pricing strength outweighs temporary production headwinds.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,391.0045.300.48%
CAC 408,666.6352.810.61%
DAX 4026,202.35201.040.77%
Dow JONES (US)54,085.88907.471.71%
FTSE 10010,879.3821.680.20%
HKSE25,881.2028.280.11%
NASDAQ26,584.99671.102.59%
Nikkei 22566,107.462,149.933.36%
NZX 50 Index13,970.9367.470.49%
S&P 5007,736.52136.021.79%
S&P/ASX 2009,213.5037.000.40%
SSE Composite Index3,873.5651.271.34%

Market Movers